Revelation Biosciences is a clinical-stage life science company focused on rebalancing inflammation using its proprietary Gemini formulation of phosphorylated hexaacyl disaccharide (PHAD), a TLR4 agonist. The company is developing GEM-AKI for acute kidney injury and GEM-CKD for chronic kidney disease. Incorporated in Delaware in 2019 and headquartered in San Diego, California, Revelation trades on Nasdaq under ticker REVB.
Q2 FY2026 — expected 2026-09-09
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-26 | 2025-12-31 | 0001193125-26-076552 | EDGAR | 82K words |
| 2025-03-06 | 2024-12-31 | 0000950170-25-034584 | EDGAR | 77K words |
| 2024-03-22 | 2023-12-31 | 0000950170-24-035322 | EDGAR | 77K words |
| 2023-03-30 | 2022-12-31 | 0000950170-23-011000 | EDGAR | 89K words |
| 2022-04-15 | 2021-12-31 | 0001213900-22-020179 | EDGAR | — |
| 2021-03-31 | 2020-12-31 | 0001213900-21-019097 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-06 | 2026-06-30 | 0001193125-26-337967 | EDGAR | 20K words |
| 2025-11-06 | 2025-09-30 | 0001193125-25-269450 | EDGAR | 18K words |
| 2025-08-08 | 2025-06-30 | 0000950170-25-105284 | EDGAR | 15K words |
| 2025-05-08 | 2025-03-31 | 0000950170-25-066897 | EDGAR | 12K words |
| 2024-11-08 | 2024-09-30 | 0000950170-24-124036 | EDGAR | 22K words |
| 2024-08-09 | 2024-06-30 | 0000950170-24-094727 | EDGAR | 19K words |
| 2024-05-10 | 2024-03-31 | 0000950170-24-057787 | EDGAR | 17K words |
| 2023-11-09 | 2023-09-30 | 0000950170-23-062025 | EDGAR | 22K words |
| 2023-08-11 | 2023-06-30 | 0000950170-23-041851 | EDGAR | 21K words |
| 2023-05-22 | 2023-03-31 | 0000950170-23-023313 | EDGAR | 20K words |
| 2022-11-10 | 2022-09-30 | 0000950170-22-024436 | EDGAR | — |
| 2022-08-15 | 2022-06-30 | 0000950170-22-017405 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-19 | 0001193125-26-357120 | EDGAR | 6K words |
| 2026-08-06 | 0001193125-26-338097 | EDGAR | 2K words |
| 2026-07-13 | 0001193125-26-302008 | EDGAR | 1K words |
| 2026-03-19 | 0001193125-26-116012 | EDGAR | 1K words |
| 2026-02-26 | 0001193125-26-076833 | EDGAR | 2K words |
| 2026-01-29 | 0001193125-26-027742 | EDGAR | 13K words |
| 2026-01-22 | 0001193125-26-018332 | EDGAR | 1K words |
| 2025-12-03 | 0001193125-25-306915 | EDGAR | 0K words |
| 2025-11-06 | 0001193125-25-269696 | EDGAR | 2K words |
| 2025-10-29 | 0001193125-25-256367 | EDGAR | 1K words |
161 total filings indexed. 133 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001810560 |
| Ticker | REVB |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Headquarters | San Diego, California |
| Website | https://www.revbiosciences.com |
| Listed | 2022-01-11 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/REVB (~200 tokens, structured JSON with cryptographic provenance)